Is there really no interest in microcap public companies? Many experts will tell you so. They will tell you that investor interest and access to capital has diminished substantially in the microcap arena.
I have a different view based on what we are seeing with our clients. Yes, the landscape has changed dramatically over the past 20 years, and yes, there are new challenges. These challenges, though, if understood correctly, create opportunity.
Challenge: The microcap value trap– Given the inability to find sell side sponsorship such as research and investment banking, microcap companies feel that they are locked in a chronic “value trap” and do not have an equity currency which justifies being public.
Opportunity: The numbers suggest something different– At October 31, 2011 the Russell 1000 index, which is comprised of the largest 1000 publicly traded companies in the U.S., had an average price to earnings multiple of 14X earnings. The Russell Microcap Index, which is comprised of the smallest publicly traded companies, had an average price to earnings multiple of 16X earnings. Quality small public companies can achieve valuations that exceed their more liquid counterparts.
Challenge: Retail brokers cannot recommend microcaps– Compliance concerns have made it virtually impossible for retail brokers to recommend microcap stocks to their clients. They can purchase the stocks in their own accounts, or take orders from clients, but they cannot recommend the stocks.
Opportunity: Emergence of the “self directed” individual investor– However, the resources and pricing for an individual investor to be active in the microcap marketplace have changed dramatically. Brokers have become financial planners and frequently individual investors will purchase individual stocks through a discount brokerage account. The presence of the “self directed” investor is in fact real and growing.
Challenge: There is no research coverage for microcaps: For public companies under $150 million market cap, there is virtually no brokerage firm research coverage available. There are exceptions, specifically some boutique research firms. Furthermore, small to mid-sized investment banks will occasionally pick up coverage to build a relationship with a company so that they are in close proximity should banking business avail itself. Nonetheless, it is true – coverage is virtually gone.
Opportunity: Buy side does their own research these days– The bottom line is that the buy side (institutional investors) do their own research in the microcap marketplace. Rarely do they depend on someone else’s models or ideas. If a public company provides thorough disclosures and minimizes information “asymmetry”, the buy side has enough data to be able to make an investment decision. Furthermore, the buy side has begun to broadcast their own research on sites such as Seeking Alpha and Sum Zero. For example, below is the description of SumZero from their home page:
“SumZero is the leading global community for buyside investment professionals. The site has rapidly grown to 5,991 elite hedge fund, private equity, and mutual fund analysts - almost every brand-name hedge fund and mutual fund is represented in SumZero’s user base. The concept is simple. There are 3,719 full-length, peer-rated investment write-ups in SumZero’s database (covering equities, credit, macro, commodities, and other asset classes). By contributing one idea, a member gains access to the entire database. Additionally, there are thousands of companies in SumZero’s database of extensively researched companies, each of which is tied to one or more buyside analysts. An analyst can easily identify a list of other leading buyside analysts who have done work on the company he/she is interested in and contact them to compare notes, deepen each other’s understanding, and build one’s professional network.”
Challenge: There are fewer and fewer institutional investors who will look at microcaps: Funds need liquidity to both buy and sell stocks. They need a certain dollar volume a day and need to be able to purchase a certain amount in order to impact their portfolio. Microcap companies not only have small market capitalization by definition, but also tend to have limited trading volume given their smaller float.
Opportunity: The proliferation of funds with smaller Assets Under Management (AUM) has created a new, large audience for Microcaps: Yes, there is limited interest in microcaps at brokerage firms given their need to focus on larger cap companies to drive trading commissions. The unfortunate reality is that the buy side doesn’t “pay” the sell side like it used to. This problem is compounded when dealing with microcap companies with low volume. Also, small managers with limited assets under management purchase smaller positions and hence are not called on by brokerage firms as much. However, for an issuer, this audience is critical. A 200,000 share trade in a $3 stock, while not a huge commission for a brokerage firm, can be very meaningful for a microcap company in building its shareholder base and average volume. So the answer is for microcap companies to not only work with the sell-side, but also to go directly to the microcap investors on their own, preferably through a quality agency such as IMS.
John Nesbett
President, IMS